Strategy Asset Managers’s iShares US Medical Devices ETF IHI Stock Holding History

Strategy Asset Managers’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-21,601	Closed	-$1.22M	–	288
2024 Q2	$1.22M	Buy	+21,601	New	+$1.21M	0.27%	71
2023 Q4	–	Sell	-21,355	Closed	-$1.04M	–	234
2023 Q3	$1.04M	Sell	21,355 -246	-1%	-$13.1K	0.27%	71
2023 Q2	$1.22M	Buy	21,601 +556	+3%	+$30.6K	0.27%	71
2023 Q1	$1.14M	Buy	21,045 +1,753	+9%	+$93.3K	0.28%	70
2022 Q4	$1.01M	Buy	19,292 +2,415	+14%	+$123K	0.26%	68
2022 Q3	$796K	Buy	16,877 +2,770	+20%	+$144K	0.22%	86
2022 Q2	$712K	Buy	14,107 +94	+0.7%	+$5.12K	0.22%	80
2022 Q1	$854K	Buy	14,013 +4,342	+45%	+$259K	0.18%	91
2021 Q4	$637K	Sell	9,671 -2,557	-21%	-$164K	0.17%	111
2021 Q3	$768K	Buy	12,228 +1,806	+17%	+$115K	0.17%	112
2021 Q2	$627K	Buy	10,422 +3,774	+57%	+$218K	0.13%	128
2021 Q1	$366K	Buy	6,648 +1,842	+38%	+$102K	0.08%	171
2020 Q4	$262K	Buy	4,806 +564	+13%	+$29.5K	0.06%	196
2020 Q3	$212K	Buy	+4,242	New	+$205K	0.06%	218

Other funds holding IHI

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Strategy Asset Managers's IHI Position: Q3 2024 in Review

Strategy Asset Managers sold out of iShares US Medical Devices ETF (IHI) in Q3 2024, closing a stake of 21,601 shares — an estimated $1.22M sold.

Strategy Asset Managers first reported a position in IHI in Q3 2020 and held it in 14 quarters. The position peaked at $1.22M in Q2 2024. 556 funds tracked by Wall St. Rank hold IHI as of Q3 2024.

Strategy Asset Managers reported no remaining iShares US Medical Devices ETF position as of Q3 2024 after selling out during the quarter.
Strategy Asset Managers sold 21,601 iShares US Medical Devices ETF shares in Q3 2024, an estimated $1.22M.
Strategy Asset Managers first reported a position in iShares US Medical Devices ETF in Q3 2020 and held it in 14 quarters.
Strategy Asset Managers's iShares US Medical Devices ETF position peaked at $1.22M in Q2 2024.
556 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2024.

Based on Strategy Asset Managers's 13F filing for Q3 2024, filed 8 Nov 2024.